Who we are
Oncolix, Inc. (Oncolix) is a clinical-stage
bio-pharmaceutical company based in
Houston,
Texas. The company is developing
Prolanta™, a targeted therapeutic protein for the treatment of ovarian
and breast cancer. The aim of Oncolix's product development is to bring
to market agents with increased efficacy and decreased toxicity in
ovarian and breast cancer therapy through targeted therapies. Prolanta™
is anticipated to be effective in the majority of these cancer patients
as this therapy targets tumors that express the prolactin receptor,
which occurs in the majority of ovarian and breast tumors.
 |
|